Statistics
Publications
14
Citations
1.7K
H-Index
14
Active since
2004
Jason Borawski is an author at Novartis (Switzerland) specializing in medicine, cell biology, and immunology.
Publications per year
2004–2020
14
14
FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
Vito Guagnano, Audrey Kauffmann, Simon Wöhrle et al. · Cancer Discovery · 2012 · 352 citations · Full text
1–5 of 14